Benzinga | Aug 31, 2021 08:05AM EDT

Maxim Group Initiates Coverage On Palisade Bio with Buy Rating, Announces Price Target of $7

Maxim Group analyst Naz Rahman initiates coverage on Palisade Bio (NASDAQ:PALI) with a Buy rating and announces Price Target of $7.